Sante Ventures engineers the luck out of fund-level venture capital returns through disciplined portfolio construction and milestone-based tranching rather than relying on unicorn exits. The firm focuses on under-ventured but research-rich regions like Texas and the Central U.S., where roughly 40% of their capital comes from eight major health systems and about half their investment team holds MDs, giving them direct strategic insight into hospital economics and care delivery.